Post-Election Briefing

Dear Research Advocate, Earlier this week, we held our Post-Election Briefing with a terrific panel featuring national public health leader Dr. Georges Benjamin, award-winning journalist Frank Sesno, and Capitol Hill veterans Cybele Bjorklund and Pete Kirkham. Through the lens of science and public health, we discussed the election results, the lame duck Congress, the upcoming 117th Congress, and a future Biden Administration. What surprised the panelists the most about the election: the high levels of voter participation despite the pandemic. Another area of consensus: the election results provide a crucial opportunity to elevate science and to rebuild our public health infrastructure ,...
Dear Research Advocate, The election is yet another way 2020 is testing us like no other year. Let’s pull through by pulling together and putting science to work as never before. The key question for us all, advocates of faster scientific, medical, and public health progress: What can we do today to advance that progress? Gather evidence and speak out . If R&D stakeholders want the next emergency package to include supplemental funding for stalled or reprogrammed research, we need to act now. Senate Majority Leader Mitch McConnell (R-KY) has said he would like to move a supplemental by the end of the year. Not only is funding needed for federal grants, but COVID has decimated grant...
Dear Research Advocate, COVID-19 : With the alarming escalation in infections and hospitals running out of beds due to the pandemic, it’s timely to stress to policymakers (and those who wish to be) that the American people want action now to improve our public health system. Today we published additional results from our recently-commissioned survey on behalf of a working group formed to address our nation’s commitment to science showing that strong majorities across the political spectrum see improving our public health system as an urgent priority . Science Strong : Please take a moment before November 3 to make the worst week of the pandemic the week every candidate connects the dots...
Dear Research Advocate, Deal or No Deal? : House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin continue to talk in hopes of clinching a bipartisan agreement on an emergency supplemental. Earlier this week, Research!America sent a letter urging them not to abandon their efforts and to include, in any agreement reached, at least $26 billion to supplement pandemic-eroded research funding. We also tweeted them (you can too!). You can also email your Members of Congress, urging them to voice support for this funding. Advocacy can’t stop now! Immigration Actions Impacting R&D : The Trump Administration, through the Department of Homeland Security (DHS), has issued proposed...
Dear Research Advocate: After Tuesday’s election, we may or may not know the exact composition of the 116th Congress, as there are likely to be some very, very close races. But there is little doubt that the picture will be clearer than it is now when it comes to the policy dynamics next year -- and that is what our post-election briefing on Thursday, November 8 from 10:00 to 11:30 a.m. EST at AAAS (1200 New York Ave, NW in Washington, DC) is all about. Register now! If history is any guide, the magnitude of change in Congress will affect the prospects for completing unfinished business during the lame-duck session of Congress; not surprisingly, the more turnover, the harder it is to build...
Dear Research Advocate: News broke this week that the Democratic Republic of the Congo (DRC) is struggling with a still-rising death toll due to Ebola, claiming more than 139 lives since July and spreading beyond the DRC. Meanwhile in the U.S., public health experts are working day and night to understand and overcome acute flaccid myelitis (AFM), now affecting children in 22 or more states. Ebola and AFM are public health crises today. It is predictable that there will be more unexpected crises on top of ongoing threats like the opioid epidemic, the increasing prevalence of obesity, chronic diseases and more. Which is why it defies common sense that investment in global health and in our...
The December 2016 Research Advocate is now online . Highlights from this month include: Research!America convened an esteemed panel of policymakers and scientists for the 2016 Post-Election Briefing on November 15 to discuss expectations for science and medical progress with a new president and the next Congress. The briefing was hosted by the American Association for the Advancement of Science and supported in part by Zogby Analytics. Post-election overview of Research!America's voter-education initiative Campaign for Cures . Federal policy update outlining the latest appropriations process in Congress, and the progress of the 21st Century Cures Act , which passed the House this week and...
Dear Research Advocate, Thanks for your indulgence; I’m afraid we’ve been flooding your inbox over the past few days. Most recently, we sent an email moving up the deadline for signing on to a letter to congressional leaders urging them to refrain from passing another Continuing Resolution (CR), and to instead complete their work on FY17 appropriations. We sent that letter out tonight, proximal to today’s announcement by House Appropriations Chairman Hal Rogers (R-KY) that he will in fact pursue a CR that would flat-fund government until March of next year (further delaying, and potentially squandering, any increase in funding for NIH and other health agencies in FY17). While his...

Sidebar Quote

If concerted, long-term investments in research are not made, America will lose an entire generation of young scientists.
Brenda Canine, PhD; McLaughlin Research Institute, Montana